ABSTRACT:
Flucytosine is an anti-fungal agent which acts against mycotic infections. The anti-mycotic activity of Flucytosine is due to its conversion in to 5-fluoro uracil. In the present study the authors have proposed a new stability indicating isocratic RP-HPLC as well as LC-APCI-MS methods for the estimation of Flucytosine and the methods are validated as per ICH guidelines. Thermo scientific - TSQ Quantis with Vanquish HPLC coupled with MS was employed for the study with Simpack C18 (250 mm x 4.6 mm x 5µm) column. A triple quadrupole mass spectrometer with atmospheric pressure chemical ionization (APCI) source, running in the positive mode (as well as negative mode) was used for the detection. A mixture of 0.1% Acetic acid: Methanol was used as mobile phase (50:50, v/v) (UV detection at 235 nm). A wide linearity concentration range 1.0-120 µg/ml was observed and the method is found to be precise and accurate and can be used for the estimation of marketed formulations. Stress degradation studies were performed and the method is found to be selective and specific.
Cite this article:
Jajili Eluru, Mukthinuthalapati Mathrusri Annapurna. A new stability indicating HPLC and LC-APCI-MS methods for the estimation of Flucytosine in pharmaceutical dosage forms. Research Journal of Pharmacy and Technology. 2023; 16(11):5296-2. doi: 10.52711/0974-360X.2023.00858
Cite(Electronic):
Jajili Eluru, Mukthinuthalapati Mathrusri Annapurna. A new stability indicating HPLC and LC-APCI-MS methods for the estimation of Flucytosine in pharmaceutical dosage forms. Research Journal of Pharmacy and Technology. 2023; 16(11):5296-2. doi: 10.52711/0974-360X.2023.00858 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-11-52
REFERENCES
1. Charles Heidelberger, Lois Griesbach, Betty Jo Montag, Dorothy Mooren and Olivia Cruz. Studies on fluorinated pyrimidines. II. Effects on transplanted tumors. Cancer Research. 1958; 18: 305-317.
2. Robert Duschinsky, Edward Pleven and Charles Heidelberger. The synthesis of 5-fluoropyrimidines. Journal of the American Chemical Society. 1957; 79(16): 4559-4560.
3. Schwertschlag U, Nakata LM and Gal J. Improved procedure for determination of Flucytosine in human blood plasma by high-pressure liquid chromatography. Antimicrobial Agents and Chemotherapy. 1984; 26(3): 303-305.
4. Serve KM, Yáñez JA, Remsberg CM, Davies NM and Black ME. Development and validation of a rapid and sensitive HPLC method for the quantification of 5-fluorocytosine and its metabolites. Biomedical Chromatography. 2010; 24(5): 556-561.
5. Bury RW, Mashford ML and Miles HM. Assay of Flucytosine (5-fluorocytosine) in human plasma by high-pressure liquid chromatography. Antimicrobial Agents and Chemotherapy. 1979; 16(5): 529-532.
6. Wade D and Sudlow G. Fluorometric measurement of 5-fluorocytosine in biological fluids. Journal of Pharmaceutical Sciences. 1973; 62(5): 828-829.
7. Mohabbat Ullah, Anisur Rahman and Saugata Dutta. Development and validation of a stability indicating RP-HPLC method for determination of Flucytosine and its process related impurities in injectable pharmaceuticals. International Journal of Advances in Pharmaceutical Analysis. 2015; 5(1): 1-9.
8. Kalyani L and Mathrusri Annapurna M. Development and validation a new stability indicating LC method for the quantification of Flucytosine. Research J. Pharm. and Tech. 2021; 14(1): 378-384.
9. Mathrusri Annapurna M, Rajasree B and Debi Prasad Pradhan. New stability indicating RP-UFLC method for the determination of Flucytosine-An anti-fungal agent. Acta Scientific Pharmaceutical Sciences. 2019; 3(5): 38-46.
10. ICH Validation of analytical procedures: Text and methodology Q2 (R1), International Conference on Harmonization (2005).
11. ICH Stability testing of new drug substances and products Q1A (R2), International Conference on Harmonization (2003).